Current Allergy and Clinical Immunology - March 2008

More documents

Recommendations

Info

$latex allerGy revisited : a review - Allergy Society of South Africa$

$Cross-reactivity of food allegens with latex - ALLSA$

PATIENT INFORMATION SHEETS –ANOTHER ALLSA MEMBERSHIP BENEFITDid you know that membership of ALLSA entitles you to receive copies of ourPatient Information Sheets which provide information on various aspects of allergyin an easy-to-understand format for your patients?Topics covered include:Allergen ImmunotherapyAllergic Reactions to Honey Bee and Wasp StingsAllergic RhinitisBedding Protectors and Allergy ControlCockroach AllergyCoeliac DiseaseContact DermatitisDrug AllergyEgg AllergyFish AllergyFood Additives and PreservativesFood AllergyHouse-Dust Mite AllergyLatex AllergyMilk Allergy/IntoleranceMould AllergyPeanut AllergyPet AllergySeafood AllergySoya AllergyTreatment of Allergic EczemaUrticaria and AngioedemaVacuuming and Allergy ControlWheat AllergyPatient information sheets can be ordered in batches of 50 from the ALLSA office,tel 021-447-9019, email mail@allergysa.orgThere is no charge for the leaflets, but we do charge for postage.50 Current Allergy & Clinical Immunology, March 2008 Vol 21, No. 1
PRODUCT NEWSNEW DESIGN FOR SYMBICORDAstraZeneca is proud to introduce a new design forSymbicord boxes and packaging. The purpose of thepackaging change is to standardise the colours anddesign globally, so that wherever in the world youmay be, the Symbicord packaging will look the same.In line with these changes, we are also keeping thesecolours for our promotional and educational material,so that the design is standardised throughout. Thenew look is bold, positive, professional and modern,with an emphasis on clinically relevant and clear information.The approach is future-focused, to reflect theconstant innovation and challenging of conventionsthat is the basis of our approach to medicine atAstraZeneca.Please note that the ingredients and doses ofSymbicord will remain the same.In conjunction with the new look, AstraZenecaintends to introduce user-friendly educational andsupport material to assist and support people withasthma.The new material is aimed at providing the busyphysician and his/her patients with the tools that theyneed so that people with asthma can take responsibilityfor their own asthma control.S 3Symbicord® Turbuhaler® 80:4,5 µg/dose (Inhaler), Reg No.35/21.5.1/0404. Each delivered dose contains as active constituents:Budesonide 80 micrograms and formoterol fumaratedihydrate 4,5 micrograms.S 3S 3Symbicord® Turbuhaler® 160:4,5 µg/dose (Inhaler), RegNo. 35/21.5.1/0405. Each delivered dose contains as activeconstituents: 160 micrograms and formoterol fumarate dihydrate4,5 micrograms.Symbicord® Turbuhaler® 320:9 µg/dose (Inhaler), Reg No.38/21.5.1/0187. Each delivered dose contains as active constituents:Budesonide 320 micrograms and formoterolfumarate dihydrate 9 microgramsNAME AND BUSINESS ADDRESS OF THE HOLDEROF THE CERTIFICATE OF REGISTRATION:AstraZeneca Pharmaceuticals (Pty) Limited, 5 Leeuwkop Road,Sunninghill, 2157, South Africa. Reg No. 92/05854/07.Tel: +27 11 797 6000. Fax: +27 11 797 6001. www.astrazeneca.co.zaHEALTHWAY EMF AIR PURIFIERWorld’s most advanced medical grade airpurifiersStudies have shown that indoor pollution is five timesmore dangerous than outdoor pollution and we spend90% of our time indoors. It seems we live in an environmenttailored to creating allergy sufferers.One of the best ways to combat allergies is to removeairborne allergens in the first place. Until recently, thiswas not possible for the average man on the street as itrequired expensive, advanced equipment.Healthway has pioneered the quest for smaller air purificationunits that are packed with all the required technologybut packaged into an affordable product.The Healthway EMF Air Purifier is one of the mostadvanced air purification systems in the world. It is certifiedby FDA as a class 2 medical device and defined as amedical air purification system.Independent laboratory testing certified that bacteriawere reduced by 98-100%, virus by 99-100% and mouldand fungi by 94-100%.The system includes dual cleanable pre-filters for largerparticulate collection. It also includes 4 pounds of granulecarbon and zeolite filter for high-capacity multiplegas/chemical scrubbing.The EMF system is 99.97% efficient at collecting 0.3microns size particulate. The 12 inch diameter EMF filteris 100% sealed so no air can bypass around the filter, toensure 100% of the air passing through the system istreated by the EMF germ-killing zone.H2O International is proud to be the exclusive distributorof this product. With a 13-year history of great service,over 70 branches nationwide and a central warehousestocked with maintenance staff and parts, you can restassured that you are buying from a well-established companythat can back you up on any after-sales service youmay need.Call H2O toll free on 0800 492 837 and receive a freeindoor quality test valued at R495.00.52 Current Allergy & Clinical Immunology, March 2008 Vol 21, No. 1
Page 6 and 7: with memory T-cell phenotypes. 18 T
Page 8 and 9: Burkholderia cepacia may be serious
Page 10 and 11: Fig. 4. Sweat test.Stage 3Lymphocyt
Page 12 and 13: AN UPDATE OF THE PRIMARY ANTIBODYDI
Page 14 and 15: lymphocytes refine the primary anti
Page 16 and 17: ange of haematological problems occ
Page 19 and 20: SEVERE COMBINED IMMUNODEFICIENCY(SC
Page 21 and 22: tinely from all neonates at birth i
Page 23 and 24: tions to the use of antiviral drugs
Page 25 and 26: therapeutic IVIG are complex. In ma
Page 27 and 28: TABLE III. Recommendations for the
Page 29 and 30: 5. Ballow M. Mechanisms of action o
Page 31 and 32: Fig. 2. Surface epidermis with unde
Page 33 and 34: sone). Unfounded steroidophobia is
Page 35 and 36: tant reaction fades by 72 hours. Fo
Page 37 and 38: try worker: case report and review
Page 39 and 40: ➞Step up if needed (first check i
Page 41: NEWSALLSA hosts a symposium at the
Page 45 and 46: PRODUCT NEWSBOEHRINGER INGELHEIM LA
Page 47 and 48: PRODUCT NEWSNASONEX IS NOW INDICATE
Page 49 and 50: PRODUCT NEWSNew Nestlé NAN H.A. 1
Page 51: INSTRUCTIONS FOR AUTHORSCurrent All

Current Allergy and Clinical Immunology - March 2008

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?